BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 8433569)

  • 1. Perlecan, the large low-density proteoglycan of basement membranes: structure and variant forms.
    Noonan DM; Hassell JR
    Kidney Int; 1993 Jan; 43(1):53-60. PubMed ID: 8433569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for the high-affinity interaction of nidogen-1 with immunoglobulin-like domain 3 of perlecan.
    Kvansakul M; Hopf M; Ries A; Timpl R; Hohenester E
    EMBO J; 2001 Oct; 20(19):5342-6. PubMed ID: 11574465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteoglycan form and function: A comprehensive nomenclature of proteoglycans.
    Iozzo RV; Schaefer L
    Matrix Biol; 2015 Mar; 42():11-55. PubMed ID: 25701227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of perlecan, a core component of basement membrane, on regeneration of cartilaginous tissues.
    Gao G; Chen S; Pei YA; Pei M
    Acta Biomater; 2021 Nov; 135():13-26. PubMed ID: 34454085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparan sulfate proteoglycans as targets for cancer therapy: a review.
    Onyeisi JOS; Ferreira BZF; Nader HB; Lopes CC
    Cancer Biol Ther; 2020 Dec; 21(12):1087-1094. PubMed ID: 33180600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SULF1 suppresses Wnt3A-driven growth of bone metastatic prostate cancer in perlecan-modified 3D cancer-stroma-macrophage triculture models.
    Brasil da Costa FH; Lewis MS; Truong A; Carson DD; Farach-Carson MC
    PLoS One; 2020; 15(5):e0230354. PubMed ID: 32413029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of Extracellular Matrix Proteins in the Cytoplasm of
    Sohail AA; Gaikwad M; Khadka P; Saaranen MJ; Ruddock LW
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31973001
    [No Abstract]   [Full Text] [Related]  

  • 8. Review of Alterations in Perlecan-Associated Vascular Risk Factors in Dementia.
    Trout AL; Rutkai I; Biose IJ; Bix GJ
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31968632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic identification of membrane-associated placental protein 4 (MP4) as perlecan and characterization of its placental expression in normal and pathologic pregnancies.
    Szenasi NL; Toth E; Balogh A; Juhasz K; Karaszi K; Ozohanics O; Gelencser Z; Kiraly P; Hargitai B; Drahos L; Hupuczi P; Kovalszky I; Papp Z; Than NG
    PeerJ; 2019; 7():e6982. PubMed ID: 31259093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A current view of perlecan in physiology and pathology: A mosaic of functions.
    Gubbiotti MA; Neill T; Iozzo RV
    Matrix Biol; 2017 Jan; 57-58():285-298. PubMed ID: 27613501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Cerebrovascular Basement Membrane: Role in the Clearance of β-amyloid and Cerebral Amyloid Angiopathy.
    Morris AW; Carare RO; Schreiber S; Hawkes CA
    Front Aging Neurosci; 2014; 6():251. PubMed ID: 25285078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Border patrol: insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue borders.
    Farach-Carson MC; Warren CR; Harrington DA; Carson DD
    Matrix Biol; 2014 Feb; 34():64-79. PubMed ID: 24001398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteome profiling of wild type and lumican-deficient mouse corneas.
    Shao H; Chaerkady R; Chen S; Pinto SM; Sharma R; Delanghe B; Birk DE; Pandey A; Chakravarti S
    J Proteomics; 2011 Sep; 74(10):1895-905. PubMed ID: 21616181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel interactions of perlecan: unraveling perlecan's role in angiogenesis.
    Bix G; Iozzo RV
    Microsc Res Tech; 2008 May; 71(5):339-48. PubMed ID: 18300285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perlecan and tumor angiogenesis.
    Jiang X; Couchman JR
    J Histochem Cytochem; 2003 Nov; 51(11):1393-410. PubMed ID: 14566013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of perlecan in skeletal development and diseases.
    Hassell J; Yamada Y; Arikawa-Hirasawa E
    Glycoconj J; 2002; 19(4-5):263-7. PubMed ID: 12975604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of proteoglycan core proteins in human bone marrow stroma.
    Schofield KP; Gallagher JT; David G
    Biochem J; 1999 Nov; 343 Pt 3(Pt 3):663-8. PubMed ID: 10527946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex patterns of alternative splicing mediate the spatial and temporal distribution of perlecan/UNC-52 in Caenorhabditis elegans.
    Mullen GP; Rogalski TM; Bush JA; Gorji PR; Moerman DG
    Mol Biol Cell; 1999 Oct; 10(10):3205-21. PubMed ID: 10512861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perlecan regulates Oct-1 gene expression in vascular smooth muscle cells.
    Weiser MC; Grieshaber NA; Schwartz PE; Majack RA
    Mol Biol Cell; 1997 Jun; 8(6):999-1011. PubMed ID: 9201711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cDNA cloning of the basement membrane chondroitin sulfate proteoglycan core protein, bamacan: a five domain structure including coiled-coil motifs.
    Wu RR; Couchman JR
    J Cell Biol; 1997 Jan; 136(2):433-44. PubMed ID: 9015313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.